Prostatitis

Prostatitis encompasses infection, inflammation, or pain of the prostate gland, affecting approximately 9.3% of men in their lifetime. [1] The NIH classifies it into four types: acute bacterial prostatitis (Type I), chronic bacterial prostatitis (Type II), chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS, Type III), and asymptomatic inflammatory prostatitis (Type IV). [1] Only 5–10% of cases have a bacterial origin; CP/CPPS accounts for >90% of chronic prostatitis. [2-3] Mean age of onset is 42 years. [2]

The following table from a 2025 JAMA review summarizes the presentation, diagnosis, and evaluation across the three symptomatic subtypes:

• Onset and tempo: Acute (hours to days) suggests bacterial prostatitis; chronic (≥3 months) suggests CBP or CP/CPPS [1]
• Urinary symptoms: Dysuria, frequency, urgency, hesitancy, straining, weak stream, incomplete emptying, urinary retention [4]
• Pain characterization: Location (perineal, suprapubic, testicular, penile, low back), radiation, relation to voiding or ejaculation [1][4]
• Systemic symptoms: Fever, chills, malaise, myalgias, arthralgias, nausea/vomiting (acute bacterial) [1][4]
• Sexual function: Ejaculatory pain, erectile dysfunction, hematospermia [2][5]
• Recurrence pattern: Prior UTIs, same organism on prior cultures (suggests CBP) [1]
• Procedural history: Recent cystoscopy, catheterization, prostate biopsy (within 6 weeks) [6-7]
• STI risk factors: Number of sexual partners, urethral discharge, condomless anal intercourse [1][6]
• Important negatives: Flank pain (pyelonephritis), testicular swelling (epididymo-orchitis), urethral discharge (STI/urethritis) [1]

• Sepsis signs: Tachycardia, hypotension, altered mental status, high fever [1][4]
• Urinary retention: Inability to void, distended bladder, overflow incontinence [1][6]
• Prostatic abscess: Persistent fever >48 hours despite appropriate antibiotics, immunosuppression, fluctuance on DRE (occurs in 3–6% of acute bacterial prostatitis) [1][4]
• Bacteremia: Present in 21% of acute bacterial prostatitis patients with fever — obtain blood cultures [1]
• Post-biopsy infection: High rates of fluoroquinolone-resistant organisms (62% ciprofloxacin resistance); consider carbapenems empirically [1]
• Failure to improve on oral antibiotics within 48–72 hours [1]

Acute Bacterial Prostatitis

• IV options (moderate-severe illness): Piperacillin-tazobactam, ceftriaxone, ciprofloxacin/levofloxacin IV; add gentamicin if MDR suspected [1]
• Oral options (mild illness): Ciprofloxacin 500 mg BID, levofloxacin 500–750 mg daily, or TMP-SMX DS BID [1][4]
• Post-biopsy: Carbapenems (meropenem), amikacin, or 2nd/3rd-gen cephalosporins per AUA [1]
• Duration: 2–4 weeks (92% cure at 2 weeks vs 97% at 4 weeks with ciprofloxacin) [1]

Chronic Bacterial Prostatitis

• First-line: Ciprofloxacin 500 mg BID or levofloxacin 500–750 mg daily × 4 weeks [1][4]
• Alternatives: TMP-SMX DS BID × 6 weeks, doxycycline 100 mg BID × 6 weeks, fosfomycin 3 g every 1–3 days × 6 weeks [1][4]
• Relapsing CBP: Repeat course up to 12 weeks with urology/ID consultation [3-4]

CP/CPPS

• First-line (with urinary symptoms): α-blockers — tamsulosin, alfuzosin (ΔNIH-CPSI −10.8 to −4.8 vs placebo) [1]
• Adjuncts: Ibuprofen (ΔNIH-CPSI −2.5 to −1.7), pregabalin (ΔNIH-CPSI −2.4), pollen extract (ΔNIH-CPSI −2.49) [1]
• Antibiotics are not recommended for CP/CPPS unless infection is identified [1]

Contraindicated/Cautions

• Prostate massage is contraindicated in acute bacterial prostatitis (risk of bacteremia) [4][8]
• Fluoroquinolones: tendinopathy risk, QT prolongation, CNS effects — weigh risk/benefit [9]
• PSA testing is not indicated during active infection (falsely elevated) [1]

• Hydration: Encourage adequate oral fluid intake to support urinary flow and antibiotic efficacy
• Acute phase: Avoid caffeine, alcohol, and spicy foods, which may exacerbate irritative voiding symptoms
• CP/CPPS: Some patients report symptom flares with caffeine, alcohol, and acidic foods; dietary modification is part of multimodal management [3]
• No high-quality evidence supports specific dietary interventions for bacterial prostatitis

• GU: Dysuria, frequency, urgency, hesitancy, retention, hematuria, hematospermia, ejaculatory pain [1-2]
• Constitutional: Fever, chills, malaise, weight loss [4]
• GI: Nausea, vomiting, constipation (pelvic floor dysfunction overlap) [4]
• MSK: Perineal, suprapubic, low back, testicular pain [4]
• Psych: Anxiety, depression, stress, difficulty coping (especially CP/CPPS — strongly associated with quality of life impairment) [1][5]
• Neuro: Neurogenic bladder symptoms if spinal cord pathology suspected [6]
• Other chronic pain syndromes: Irritable bowel syndrome, interstitial cystitis, fibromyalgia, chronic fatigue syndrome (associated with CP/CPPS) [2][5]

• Sexual history: Partners, STI history, condom use, anal intercourse [1][6]
• Prior UTI history: Frequency, organisms, antibiotic susceptibilities (critical for CBP diagnosis) [1]
• Procedural history: Recent prostate biopsy, cystoscopy, catheterization [6-7]
• Family history: BPH, prostate cancer (relevant for differential diagnosis, not direct prostatitis risk)
• Social context: Occupational prolonged sitting, cycling (anecdotally associated with perineal symptoms), psychological stressors (CP/CPPS) [5]

• Urinary tract instrumentation: Catheterization, cystoscopy, prostate biopsy [6-7]
• Urinary obstruction: BPH, urethral stricture [1][6]
• Immunosuppression: Diabetes, HIV, transplant recipients [1][6]
• Neurological conditions: Multiple sclerosis, stroke, spinal cord injury (neurogenic bladder) [6]
• Condomless anal intercourse [6]
• Prior UTIs or prostatitis episodes [1][3]
• Younger age (mean onset ~42 years for chronic prostatitis) [2]
• Psychological factors (stress, anxiety, depression — particularly for CP/CPPS) [2][5]

Acute presentation

• Acute cystitis — dysuria/frequency without fever/chills, no prostatic tenderness [1]
• Pyelonephritis — fever + flank pain + CVA tenderness [1]
• Epididymo-orchitis — testicular enlargement, induration, tenderness [1]
• STIs (gonorrhea/chlamydia) — urethral discharge, dysuria [1]
• Prostatic abscess — persistent fever despite antibiotics, fluctuance on DRE [4]

Chronic presentation

• BPH — obstructive symptoms without pain, enlarged non-tender prostate [1]
• Bladder or prostate cancer — hematuria, weight loss, hard/nodular prostate [1][4]
• Urethral stricture — progressive obstructive symptoms [1]
• Interstitial cystitis/bladder pain syndrome — suprapubic pain, frequency, negative cultures [3-4]
• Urolithiasis — colicky flank/groin pain, hematuria [1]
• Pelvic floor dysfunction — overlapping pain patterns, tenderness on pelvic floor exam [3]
• Neuropathic pain / ejaculatory duct obstruction [4]

• Prior episodes of prostatitis or UTIs (recurrence pattern, organisms, susceptibilities)
• History of BPH, urethral stricture, or urologic surgery
• Recent prostate biopsy or urologic instrumentation
• Immunocompromising conditions (diabetes, HIV, transplant)
• Neurologic conditions affecting bladder function
• Chronic pain syndromes (fibromyalgia, IBS, interstitial cystitis — associated with CP/CPPS) [2][5]
• Medication history: prior antibiotic courses and susceptibility data from last 1–2 years [1]

• Vitals: Temperature, heart rate, blood pressure (assess for sepsis) [4]
• Abdominal exam: Suprapubic tenderness, palpable/distended bladder (retention) [4]
• Genital exam: Testicular/epididymal tenderness, swelling, induration (rule out epididymo-orchitis); urethral discharge (STI) [1]
• Digital rectal examination (DRE):
  • Acute bacterial: Prostate is tender, boggy, enlarged/edematous in 77–90% of cases [1][4]
  • Chronic bacterial: May feel normal, tender, or boggy [4]
  • CP/CPPS: Variable tenderness; assess pelvic floor tenderness [1][4]
  • Do NOT perform prostate massage in acute prostatitis (bacteremia risk) [4][8]
• Assess for prostatic nodularity/induration (concern for malignancy) [1]

• Urinalysis: Leukocyte esterase (sensitivity 81–83%), nitrites (specificity 90–94%) [1]
• Urine culture: Obtain before antibiotics in all suspected cases — definitive diagnosis [1]
• Blood cultures: If febrile (21% bacteremia rate in acute bacterial prostatitis) [1]
• CBC with differential, BMP (electrolytes, creatinine): Assess for leukocytosis, renal function [4]
• STI testing: Urine NAAT for gonorrhea/chlamydia if risk factors present [1]
• PSA: Not indicated during acute infection; defer until infection treated if cancer screening needed [1]
• 4-glass or 2-glass Meares-Stamey test: Criterion standard for chronic bacterial prostatitis diagnosis; 10-fold increase in colony count in post-massage specimen (VB3) vs pre-massage (VB2) confirms diagnosis [1][4][8]

• First-line: Not routinely required for uncomplicated acute bacterial prostatitis [7]
• Bladder scan/ultrasound: Postvoid residual measurement if urinary retention suspected [1]
• Pelvic CT: Indicated for prostatic abscess evaluation when:
  • Immunosuppressed [1]
  • High fever or persistent fever >48 hours despite appropriate antibiotics [1][4]
  • Poor response to treatment or delayed presentation [1]
  • Persistent pelvic discomfort in CBP despite adequate antibiotic course [1]
• CT abdomen/pelvis or ultrasound: If hematuria, flank pain, or concern for urolithiasis/ureteral obstruction [1]
• Transrectal ultrasound: Alternative for abscess evaluation [4]

• NIH-Chronic Prostatitis Symptom Index (NIH-CPSI): Scale 0–43; used to establish CP/CPPS severity and monitor treatment response; 6-point change is clinically meaningful [1]
• UPOINT classification (Urinary, Psychosocial, Organ-specific, Infection, Neurologic/systemic, Tenderness): Phenotypic framework to guide multimodal CP/CPPS treatment [3]
• Meares-Stamey 4-glass test / modified 2-glass test: Diagnostic standard for CBP [1][8]
• Postvoid residual (PVR): Bladder scan or catheterization to assess for retention [1]
• Point-of-care ultrasound: Bladder volume assessment in the ED

• Not routinely indicated for prostatitis
• Obtain ECG if:
  • Sepsis with hemodynamic instability
  • Planning to use fluoroquinolones in patients with QT prolongation risk factors (concomitant QT-prolonging drugs, electrolyte abnormalities, cardiac history)
  • Tachycardia or arrhythmia on presentation

Prostatitis is classified into distinct syndromes requiring different diagnostic and therapeutic approaches: [1]

• Acute bacterial prostatitis: Acute febrile UTI with prostatic involvement; caused by gram-negative organisms (E. coli, Klebsiella, Pseudomonas) in 80–97% of cases; can progress to sepsis, abscess, or urinary retention [1]
• Chronic bacterial prostatitis: Persistent/recurrent UTIs from the same organism; 4–10% of chronic prostatitis; typically not systemically ill [1]
• CP/CPPS: Pelvic pain ≥3 months without identifiable infection; diagnosis of exclusion; strongly associated with psychosocial comorbidity and decreased quality of life [1][5]
• Complications to consider: Prostatic abscess (3–6% of acute cases), bacteremia (21%), urinary retention, progression to chronic prostatitis, infertility [1][4]

The following algorithm from the AAFP outlines the diagnosis and treatment approach for acute bacterial prostatitis:

Acute Bacterial Prostatitis — Initial Stabilization

• IV fluid resuscitation if septic or dehydrated
• Urinary catheter placement if retention present [1]
• Obtain urine culture and blood cultures (if febrile) before antibiotics [1]

Antibiotic Selection

• Mild illness (outpatient): Oral ciprofloxacin, levofloxacin, or TMP-SMX [1]
• Moderate-severe illness (inpatient): IV piperacillin-tazobactam, ceftriaxone, or fluoroquinolone; add aminoglycoside if MDR suspected [1]
• Post-biopsy: Carbapenems, amikacin, or 2nd/3rd-gen cephalosporins [1]
• Duration: 2–4 weeks [1]

Chronic Bacterial Prostatitis

• Fluoroquinolone × 4 weeks (first-line) or TMP-SMX/doxycycline/fosfomycin × 6 weeks [1][4]
• Relapsing cases: 12-week course with specialist consultation [4]

CP/CPPS — Multimodal Approach

• α-blockers (tamsulosin, alfuzosin) for urinary symptoms [1]
• NSAIDs (ibuprofen) for pain [1]
• Pregabalin or pollen extract as adjuncts [1]
• Pelvic floor physical therapy [2-3]
• Psychological support for anxiety/depression/catastrophizing [5]

Admission criteria

• Sepsis or hemodynamic instability [1]
• Inability to tolerate oral intake (nausea/vomiting) [1]
• Urinary retention requiring catheterization [1]
• Suspected prostatic abscess [4]
• Recent prostate biopsy with febrile infection (high MDR risk) [1]
• Prior MDR infection or failure of oral therapy at 48–72 hours [1]

Discharge criteria (outpatient management)

• Hemodynamically stable, afebrile or low-grade fever
• Tolerating oral intake
• No urinary retention
• No risk factors for MDR organisms
• Reliable follow-up [7]

Specialist consultation triggers

• Prostatic abscess → Urology ± IR for drainage [4]
• MDR organisms → Infectious disease [9]
• Refractory CP/CPPS → Urology [3]
• Recurrent/relapsing CBP → Urology + ID [4]

Follow-up timing

• Acute bacterial prostatitis (outpatient): 48–72 hours for clinical reassessment and culture review [1]
• Chronic bacterial prostatitis: Repeat urine culture after completing antibiotic course to confirm eradication [1]
• CP/CPPS: Urology follow-up within 2–4 weeks; NIH-CPSI reassessment for treatment response [1]

Return precautions — instruct patients to return immediately for:

• Worsening or persistent fever >48 hours on antibiotics
• Inability to urinate or worsening urinary retention
• Rigors, lightheadedness, or signs of sepsis
• Inability to tolerate oral medications or fluids
• New or worsening perineal/pelvic pain

Patient counseling

• Complete the full antibiotic course even if symptoms improve
• Avoid sexual activity during acute infection treatment
• Adequate hydration
• Acute bacterial prostatitis has a 92–97% cure rate with appropriate antibiotics [1]
• CP/CPPS is a chronic condition; multimodal therapy and realistic expectations are important [3][5]

1. Prostatitis. — Borgert BJ, Wallen EM, Pham MN. The Journal of the American Medical Association. 2025.

2. Non-Pharmacological Interventions for Treating Chronic Prostatitis/­Chronic Pelvic Pain Syndrome. — Franco JV, Turk T, Jung JH, et al. The Cochrane Database of Systematic Reviews. 2018.

3. Common Questions About Chronic Prostatitis. — Holt JD, Garrett WA, McCurry TK, Teichman JM. American Family Physician. 2016.

4. Acute and Chronic Prostatitis. — Lam JC, Stokes W. American Family Physician. 2024.

5. Pharmacological Interventions for Treating Chronic Prostatitis/­Chronic Pelvic Pain Syndrome. — Franco JV, Turk T, Jung JH, et al. The Cochrane Database of Systematic Reviews. 2019.

6. What Is Prostatitis?. — Voelker R. The Journal of the American Medical Association. 2026.

7. Acute Bacterial Prostatitis: Diagnosis and Management. — Coker TJ, Dierfeldt DM. American Family Physician. 2016.

8. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.

9. How I Manage Bacterial Prostatitis. — Lam JC, Lang R, Stokes W. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2023.